Company: NGVT
Filing Date: 2025-03-31
Form Type: DEFA14A
Source: 0001140361-25-011160
Chunk: 1

Company: Ingevity Corp
Filing Date: 2025-03-31
Form: DEFA14A
Chunk 1
---
ursuant to the Cooperation Agreement, the Company agreed to (i) appoint F. David Segal to the Company’s Board of Directors (the “ Board ”) within one day of the 2025 annual meeting of stockholders (the “ 2025 Annual Meeting ”), (ii) appoint Mr. Segal to the Audit Committee of the Board and (iii) not increase the size of the Board to more than eleven directors until the earliest date pursuant to which stockholder nominations for director elections are
    permitted to be delivered pursuant to the Company’s bylaws for the Company’s 2026 annual meeting of stockholders (the “ Expiration Date ”). The Cooperation Agreement provides that the Company and Vision One parties will cooperate in good faith to
    select a mutually agreeable replacement director in the event that Mr. Segal ceases to serve as a director before the Expiration Date.

Pursuant to the Cooperation Agreement, the Vision One Parties agreed to withdraw their nominees for the 2025 Annual Meeting and to abide by certain customary standstill restrictions, mutual non-disparagement provisions,
    voting commitments, including supporting each director nominated and recommended by the Board for election, and other obligations until the Expiration Date.

The foregoing description of the Cooperation Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Cooperation Agreement, a copy of which is attached as Exhibit 10.1
    to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on March 30, 2025.